IJCM  Vol.7 No.4 , April 2016
Risk Factors, Clinical Features, Baseline Alanine Aminotransferase and CD4+ Count of Children with HIV Co-Infection with Hepatitis B and C at a Tertiary Hospital in Southwest Nigeria
Abstract: Background: Human immunodeficiency virus and hepatitis B and C viruses are endemic in sub- Saharan African countries including Nigeria. Researchers have studied the burden of co-infection of HIV with hepatitis B and hepatitis C but the risk factors and clinical presentation have not been much addressed especially in children. Methodology: This was a prospective cross sectional study that determined the prevalence, risk factors, clinical features, baseline CD4+ count, CD4+ percentage, and alanine aminotransferase (ALT) of newly diagnosed, HAART na?ve HIV co-infection among children who were managed at a Tertiary Hospital in Ilorin, Nigeria. Result: Of the 60 HIV- infected children recruited, 11.7% had HIV co-infection with HBV or HCV. Children with co-infec- tions (mean age 8.43 ± 2.37 years) were significantly older than their HIV mono-infected counterparts (mean age 5.25 ± 3.96 years) (p = 0.011). There was no significant difference between HIV monoinfection and HIV co-infection with respect to gender (p = 0.758), ethnicity (p = 0.707), religion of parents (p = 0.436), family type (p = 0.184), social class (p = 0.535), previous transfusion (p = 0.053), scarification (p = 0.612), female genital mutilation (p = 0.778), and sharing of clippers (p = 0.806). The mean BMI, immunological staging (p = 0.535), baseline ALT (p = 0.940), and mean baseline CD4+ count (p = 0.928) were comparable. However, the body mass index of HIV co-infec- ted children decreased with age up till age 10 years. Conclusion: There were no risk factors, nor clinical features predictive of co-infection identified in this study. Co-infection did not negatively impact baseline, CD4+ count and ALT.
Cite this paper: Durowaye, M. , Ernest, S. and Ojuawo, I. (2016) Risk Factors, Clinical Features, Baseline Alanine Aminotransferase and CD4+ Count of Children with HIV Co-Infection with Hepatitis B and C at a Tertiary Hospital in Southwest Nigeria. International Journal of Clinical Medicine, 7, 280-291. doi: 10.4236/ijcm.2016.74030.

[1]   Cooley, L. and Sasadeusz, J. (2003) Clinical and Virological Aspects of Hepatitis B Co-Infection in Individuals Infected with Human Immunodeficiency Virus Type-1. Journal of Clinical Virology, 26, 185-193.

[2]   Main, J. and McCarron, B. (2005) Hepatitis in HIV-Infected Persons. In: Thomas, H., Lemon, S. and Zuckerman, A., Eds., Viral Hepatitis, 3 Edition, Blackwell Publishing Ltd., Massachusetts, 769-779.

[3]   Zhou, S., Zhao, Y., He, Y., Li, H., Bulterys, M. and Sun, X. (2010) Hepatitis B and Hepatitis C Seroprevalence in Children Receiving Antiretroviral Therapy for Human Immunodeficiency Virus-1 Infection in China, 2005-2009. Journal of Acquired Immune Deficiency Syndromes, 54, 191-196.

[4]   Koziel, M. and Peters, M. (2007) Viral Hepatitis in HIV Infection. The New England Journal of Medicine, 356, 1445-1454.

[5]   Adewole, O.O., Anteyi, E., Ajuwon, Z., Wada, I., Elegba, F., Ahmed, P., et al. (2009) Hepatitis B and C Virus Co-In-fection in Nigerian Patients with HIV Infection. Journal of Infection in Developing Countries, 3, 369-375.

[6]   Rockstroh, J. (2006) Influence of Viral Hepatitis on HIV Infection. Journal of Hepatology, 44, 25-27.

[7]   Schnuriger, A., Dominguezd, S., Guiguete, M., Harfoucha, S., Samria, A., Ouazeneh, Z., et al. (2009) Acute Hepatitis C in HIV-Infected Patients: Rare Spontaneous Clearance Correlates with Weak Memory CD4 T-Cell Responses to Hepatitis C Virus. AIDS, 23, 2079-2089.

[8]   Christian, B., Okuma, J. and Hawkins, H. (2010) Prevalence of Hepatitis B and C Co-Infection and Response to Antiretroviral Therapy among HIV-Infected Patients in an Urban Setting in Tanzania. 17th Conference on Retroviruses & Opportunistic Infections (CROI 2010), San Francisco, 16-19 February 2010.

[9]   Rawizza, H., Ochigb, O.S., Chang, C., MeloniI, M., Oguche, S., Osinusi, I.K., et al. (2010) Prevalence of Hepatitis Co-Infection among HIV-Infected Nigerian Children in the Harvard. PEPFAR ART Program Conference on Retroviruses and Opportunistic Infections, San Francisco.

[10]   Kotzee, T., Pronyk, P., Vardas, E., Heyer, A. and Martinson, N. (2006) HIV and Hepatitis B Co-Infection in Southern Africa: A Review for General Practitioners. Southern African Journal of HIV Medicine, 7, 38-43.

[11]   Law, W.P., Duncombe, C.J., Mahanontharit, A., Boyd, M.A., Ruxrungtham, K., Lange, J.M., et al. (2004) Impact of Viral Hepatitis Co-Infection on Response to Antiretroviral Therapy and HIV Disease Progression in the HIV-NAT Cohort. AIDS, 18, 1169-1177.

[12]   Idoko, J., Meloni, S., Muazu, M., Hawkins, C., Bidang, B., Gwamzi, N., et al. (2007) Hepatitis B Virus Co-Infection Impacts Baseline HIV Parameters and HAART-Related Hepatotoxicity Risk in an HIV-Infected Nigerian Cohort. AIDS Prevention Initiative in Nigeria.

[13]   Otegbayo, J., Adewole, I., Taiwo, B., Akingbola, T., Odaibo, G., Adedapo, K., et al. (2008) Prevalence of Hepatitis B and C Seropositivity in a Nigerian Cohort of HIV-Infected Patients. Annals of Hepatology, 7, 152-156.

[14]   Mandala, J., Torpey, K., Kasonde, P., Kabaso, M., Dirks, R., Suzuki, C., et al. (2009) Prevention of Mother-to-Child Transmission of HIV in Zambia: Implementing Efficacious ARV Regimens in Primary Health Centers. BMC Public Health, 9, 314.

[15]   Yogev, R. and Chadwick, E. (2007) Acquired Immunodeficiency Syndrome (Human Immunodeficiency Virus). In: Kliegman, R., Behrman, R., Jenson, H. and Stanton, B., Eds., Nelson Textbook of Pediatrics, 18th Edition, Saunders Elsevier, Philadelphia, 1427-1442.

[16]   Mboto, C., Fielder, M., Davies-Russell, A. and Jewell, A. (2009) Prevalence of HIV-1, HIV-2, Hepatitis C and Co-Infection in the Gambia. West African Journal of Medicine, 28, 306-309.

[17]   Yazigi, N. and Balistreri, W. (2007) Viral Hepatitis. In: Kliegman, R., Behrman, R., Jenson, H. and Stanton, B., Eds., Nelson Textbook of Pediatrics, 18th Edition, Saunders Elsevier, Philadelphia, 1680-1690.

[18]   Hoffmann, C.J. and Thio, C.L. (2007) Clinical Implications of HIV and Hepatitis B Co-Infection in Asia and Africa. The Lancet Infectious Diseases, 7, 402-409.

[19]   Jan-Christian, W. (2010) Hepatitis B—Epidemiology, Transmission and Natural History. In: Mauss, S., Berg, T., Rockstroh, J., Sarrazin, C. and Wedemeyer, H., Eds., Hepatology, 2nd Edition, Flying Publisher, Wuppertal, 7-17.

[20]   Shepard, C., Simard, E., Finelli, L., Fiore, A. and Bell, B. (2006) Hepatitis B Virus Infection: Epidemiology and Vaccination. Epidemiologic Reviews, 28, 112-125.

[21]   Francis, D., Favero, M. and Maynard, J. (1981) Transmission of Hepatitis B Virus. Seminars in Liver Disease, 1, 27-32.

[22]   Polizzotto, M., Wood, E., Ingham, H. and Keller, A. (2008) Reducing the Risk of Transfusion-Transmissible Viral Infection through Blood Donor Selection: The Australian Experience 2000 through 2006. Transfusion, 48, 55-63.

[23]   Dodd, R. (2000) Current Viral Risks of Blood and Blood Products. Annals of Medicine, 32, 469-474.

[24]   La Torre, G., Miele, L., Chiaradia, G., Mannocci, A., Reali, M., Gasbarrini, G., et al. (2007) Socio-Demographic Determinants of Coinfections by HIV, Hepatitis B and Hepatitis C Viruses in Central Italian Prisoners. BMC Infectious Diseases, 7, 100.

[25]   Saravanan, S., Velu, V., Kumarasamy, N., Nandakumar, S., Murugavel, K.G., Balakrishnan, P., et al. (2007) Coinfection of Hepatitis B and Hepatitis C Virus in HIV-Infected Patients in South India. World Journal of Gastroenterology, 13, 5015-5020.

[26]   Sadoh, A., Sadoh, W. and Iduoriyekemwen, N. (2011) HIV Co-Infection with Hepatitis B and C Viruses among Nigerian Children in an Antiretroviral Treatment Programme. South African Journal of Child Health, 5, 7-10.

[27]   Telatela, S.P., Matee, M.I. and Munubhi, E.K. (2007) Seroprevalence of Hepatitis B and C Viral Co-Infections among Children Infected with Human Immunodeficiency Virus Attending the Paediatric HIV Care and Treatment Center at Muhimbili National Hospital in Dar-es-Salaam, Tanzania. BMC Public Health, 7, 338.

[28]   Chukwuka, J., Ezechukwu, C. and Egbuonu, I. (2003) Cultural Influences on Hepatitis B Surface Antigen Seropositivity in Primary School Children in Nnewi. Nigerian Journal of Paediatrics, 30, 140-142.

[29]   Sulkowski, M.S., Thomas, D.L., Mehta, S.H., Chaisson, R.E. and Moore, R.D. (2002) Hepatotoxicity Associated with Nevirapine or Efavirenz-Containing Antiretroviral Therapy: Role of Hepatitis C and B Infections. Hepatology, 35, 182-189.

[30]   Cheruvu, S., Marks, K. and Talal, A.H. (2007) Understanding the Pathogenesis and Management of Hepatitis B/HIV and Hepatitis B/Hepatitis C Virus Coinfection. Clinical Liver Disease, 11, 917-943.

[31]   Lodenyo, H., Schoub, B., Ally, R., Kairu, S. and Segal, I. (2000) Hepatitis B and C Virus Infections and Liver Function in Aids Patients at Chris Hani Baragwanath Hospital, Johanneburg. East African Medical Journal, 77, 13-15.

[32]   Shire, N., Welge, J. and Sherman, K. (2006) Efficacy of Inactivated Hepatitis A Vaccine in HIV-Infected Patients: A Hierarchical Bayesian Meta-Analysis. Vaccine, 24, 272-279.

[33]   Laurence, J. (2005) Hepatitis A and B Immu-Nizations of Individuals Infected with Human Immunodeficiency Virus. American Journal of Medicine, 118, 75S-83S.

[34]   Gandhi, R. (2005) Response to Hepatitis B Vaccine in HIV-1-Positive Subjects Who Test Positive for Isolated Antibody to Hepatitis B Core Antigen: Implications for Hepatitis B Vaccine Strategies. The Journal of Infectious Diseases, 191, 1435-1441.

[35]   Operskalski, E. and Andrea, K. (2011) HIV/HCV Co-Infection: Pathogenesis, Clinical Complications, Treatment, and New Therapeutic Technologies. Current HIV/AIDS Reports, 8, 12-22.

[36]   Nyirenda, M., Beadsworth, M., Stephany, P., Hart, C., Hart, I., Munthali, C., et al. (2008) Prevalence of Infection with Hepatitis B and C Virus and Coinfection with HIV in Medical Inpatients in Malawi. Journal of Infection, 57, 72-77.

[37]   Benhamou, Y., Bochet, M., Thibault, V., Di Martino, V., Caumes, E., Bricaire, F., et al. (1999) Long-Term Incidence of Hepatitis B Virus Resistance to Lamivudine in Human Immunodeficiency Virus-Infected Patients. Hepatology, 30, 1302-1306.

[38]   Hirsch, H.H., Kaufmann, G., Sendi, P. and Battegay, M. (2004) Immune Reconstitution in HIV-Infected Patients. Clinical Infectious Diseases, 38, 1159-1166.

[39]   Rouet, F., Chaix, M.L., Inwoley, A., Anaky, M.F., Fassinou, P., Kpozehouen, A., et al. (2008) Frequent Occurrence of Chronic Hepatitis B Virus Infection among West African HIV Type-1-Infected Children. Clinical Infectious Diseases, 46, 361-366.

[40]   Oyedeji, G.A. (1984) The Present Day Epidemiology of Severe Protein-Energy Malnutrition in Nigeria. Clinical Pediatrics, 23, 623-628.

[41]   Blumberg, B. (1971) The Discovery of Australian Antigen and Its Relation to Viral Hepatitis. Vitro, 7, 223.

[42]   Kuo, G., Choo, Q., Alter, H. and Houghton, M. (1989) An Assay for Circulating Antibodies to a Major Etiologic Virus of Human Non-A, Non-B Hepatitis. Science, 244, 362-364.

[43]   Wilber, J. (1993) Development and Use of Laboratory Tests for Hepatitis C Infection: A Review. Journal of Clinical Immunoassay, 16, 204-207.

[44]   Durowaye, M., Ernest, S. and Ojuawo, I. (2014) Prevalence of HIV Co-Infection with Hepatitis B and C Viruses among Children at a Tertiary Hospital in Ilorin, Nigeria. International Journal of Clinical Medicine Research, 1, 42-47.

[45]   Centers for Disease Control, US Department of Health and Human Services (1986) Classification System for Human T-Lymphotropic Virus Type III/Lymphadenopathy-Associated Virus Infections. Annals of Internal Medicine, 105, 234-237.

[46]   Snyder, J.D. and Pickering, L.K. (2010) Viral Hepatitis. In: Kliegman, R.M., Stanton, B., Geme, J.W., Schor, N.F. and Behrman, R.E., Eds., Nelson Textbook of Pediatrics, 19th Edition, Elsevier Inc., Philadelphia, 1324-1331.

[47]   Safrin, S. (2004) Antiviral Agents. In: Katzung, B.G., Masters, S.B. and Trevo, A.J., Eds., Basic and Clinical Pharmacology, 9th Edition, The McGraw-Hill Companies, Inc., China, 1117-1156.